Angelike Kefalas, Mba Email & Phone Number

Toronto, Ontario, CA

Interaxon (Muse Health AI) is a pioneering brain health company that is on a mission to improve neurological conditions through its industry-leading EEG neurofeedback platform, built on advanced A.I. algorithms.

Southampton, Hampshire, GB

TopMD is a genomics A.I. technology driven SaaS data science company that uses Next Generation Sequencing (NGS) outputs along with deep learning and pattern discovery steps associated with A.I. to power a Discovery Engine Platform that serves as a "molecular GPS". By using genomic sequencing and identifying biomarker targets and pathways, TopMD Precision.

• Renegade.bio was a COVID PCR laboratory that shifted to a CLIA specialty diagnostic testing and genomic sequencing laboratory. I worked closely with the CEO, leadership team, and Board to drive all aspects of the.
• Some of my responsibilities included directing and leading a team of 15 people in Sales, Marketing, Customer Service as well as setting commercial strategy, corporate development, product pipeline expansion, and payer.
• Negotiated and closed a 6,000+ clinic and hospital channel partner agreement (within 6 months of being hired)
• Led corporate and brand awareness campaigns which led to several TV news and media interviews

White Plains, New York, US

Trellus Health is a digital health / telehealth solution combining validated resilience-driven mental health tools along with a coordinated clinical care team of healthcare professionals for better outcomes along with cost savings. I helped the Executive Team and Founders strategize and execute on business expansion ideas, marketing, and sales channel.

San Francisco, CA, US

• Pinpoint Science was an In Vitro Diagnostic (IVD) & bioinformatics start-up developing a point-of-care medical device (handheld reader + disposable cartridge + App). Pinpoint’s technology used molecular electronic.
• I led multiple departments including: Business Development, Sales, Marketing, Market Research, Competitive Intelligence, Financial Planning & Analysis and Commercial Operations
• I also created and led U.S. and Global go-to-market (GTM) commercial product launch plans
• Served as the commercial perspective / 'voice of the customer' to the product teams which include engineering, software and clinical.
• Developed and orchestrated short- and long-term global strategy and sales frameworks, including organizational structure, goal setting, customer growth, customer type and channel strategy
• Sourced, negotiated and signed development partnership deals, sales channel deals and licensing deals with pharmaceutical companies.

San Francisco, CA, US

San Francisco, CA, US

Wrote business plan Collaborated with founders to raise SEED round with Angel investors as well as apply for Federal NIH Grants. Led business development, FDA regulatory planning, strategic business planning as well as multiple product development initiatives bringing customer voice to software and hardware development teams

• Medicines360 is a biopharmaceutical company.
• Globally launched Liletta® /Avibela® an FDA approved medical product with co-promote partner Allergan, in a highly competitive $5B market of Women’s Reproductive Health. My GTM and Launch awareness tactics created.
• Built, scaled and oversaw sales team and implemented processes including Playbooks, Sales Methodologies, and Sales Stage Management Guides. Also implemented Salesforce.com as the companies CRM reporting tool
• Developed a commercial enablement strategy with a focus on increasing rep knowledge, facilitating the deal cycle, and improved rep onboarding and eLearning curriculum
• In addition, I was responsible for developing product positioning, branding and implementing a cohesive Marketing, Sales and Go to Market (GTM) Launch plan—with P&L responsibility for Liletta® including the execution.
• Hired, inspired and directed an internal team as well as multiple external consultants and Agencies on the creation of 500+ original promotional content materials—with a $MM budget.

Amplify Health was a SaaS health data analytics (EMR / EHR integration) startup. I was hired by the CEO Founder to clearly articulate the company's brand and positioning, communicating complex ideas and workflows into an understandable narrative and sales pitch. Conducted customer research to identify product value and created a new website, marketing.

• Tethys Bioscience, Inc. was a cardiometabolic In Vitro Diagnostic (IVD) company (molecular assay + algorithm) that commercialized PreDx.
• I was hired in 2011 by new CEO, to turn-around a failed product launch and drive product awareness, revenue growth and market position worldwide, while optimizing commercial operations.
• Created new physician and patient customer acquisition and retention initiatives that drove up awareness and sales—and in 6 months doubled sales.
• Implemented cutting-edge marketing tactics, promotional partnerships (Biggest Loser TV show, LoseIt App, WebMD) and new product offerings that led to increased customer engagement and exponential sales funnel.
• Proactively identified commercial opportunities and obstacles and developed innovative solutions
• Led and managed Commercial Operations, Market Research, Competitive Intelligence, Marketing, and Sales Analytics (implementing Salesforce.com as a new CRM for Sales tracking & reporting)

San Francisco, CA, US

• UCSF CANCER CENTER (Mt. Zion)Part of the founding team of the Cancer UC Collaborative project with world renowned cancer surgeon who keeps challenging the status quo with a focus of “no two cancer patients should be.
• I co-led 3 teams— the Pathology, BioBank/BioRepository and Radiology teams—consisting of top cancer pathologists, surgeons, oncologists, and radiologists from all 5-UC Cancer Hospitals (UCLA, UCSF, UC Davis, UCSD, UC.
• The Cancer Collaborative project raised >$25M to successfully connect for the first time all 5 U.C. Cancer Centers, on a Big Data scale.
• Built Knowledge Networks by sharing data, knowledge, and ideas which helped both scientists and physicians build on knowledge gained by others to advance the field of cancer medicine.
• The project also funded the infrastructure needed to make it easier to share data and knowledge.
• One of the primary goals of the project was to break down research silos, fostering collaboration, reshaping research culture, and providing physicians and researchers access to top-notch resources—including access to.

• Launched Qutenza®, an FDA approved therapeutic treatment of pain associated with Post-Herpetic Neuralgia (PHN) sold through Specialty Pharmacy channels.
• Executed a variety of marketing tactics that were Physician, Patient or Payer directed as well as supported the sales growth at Specialty clinics and Hospitals.
• Multi-Channel Marketing efforts included: HCP and Patient materials, Digital Marketing (search optimization, blog Ads, YouTube Videos, FaceBook Ads, Google Ad word buys, Email campaigns), Patient Advocacy Campaigns.
• Ran the “Promotional and Advertising Review Committee” (PARC) that reviewed marketing materials and communications from a regulatory and compliance perspective (FDA, PDMA, and PhRMA).NeurogesX (acquired by Acorda.

Abbott Park, Illinois, US

• Hired by and reported to the Chief Commercial Officer (CCO) to be a change agent and ignite sales—charged with turning around a failing product brand that was losing market share quarter after quarter. Led several.
• Led the FreeStyle® brand team through the process of rebranding, deriving consumer insights from segmentation research and patient journey market research. *Rebranding efforts led to immediate increases in sales and.
• Led the “Strategic Market Planning Process” which included drafting: commercial plan tactics, competitive sales playbooks, SWOT analyses, forecasts, and life-cycle plans (LCPs).
• Worked closely with Commercial Sales Force Area Heads (US, EU, Latin America, Asia Pac) and R&D teams to support launched to early-phase products.
• Trained in public speaking and spoke at several sales meetings that consisted of 2,000 sales reps.
• Performed multiple in-licensing evaluations with a focus on M&A and strategic partnerships.

• NUVELO was a publicly-traded biotech developing Cardiovascular and Cancer products.
• Led Market Research and customer insight work for newly created Commercial Department.
• Also, an integral part of developing a cohesive global go-to-market Marketing and Sales plan for ALFIMEPRASE®, a 510 (k) medical device drug product that was partnered to Bayer Pharmaceuticals for ex-US.
• In addition, I was the commercial Team Member Lead to several pipeline products for the treatment of cancer. Activities included: refining TPPs, identifying the value proposition, competitive analysis, product.

San Francisco, California, US

• Nektar is a publicly traded biotechnology company with 1,000-2,000 employees.
• Project Team Leader for 5 new products. Created clear goals, supported efforts, and ensured project alignment across senior management & departments.
• Wrote mini-business plans for each therapeutic product under consideration for pipeline inclusion and resource funding. Mini-business plans incorporated cross-functional project team ideas to mitigate development risk.
• Part of a product prioritization effort (after an M&A), I analyzed 50+ therapeutic product opportunities. Presented go/no-go assessments to senior management for decisions.

Emeryville, California, US

• XOMA was a publicly-traded biotechnology company focused on developing therapeutic humanized monoclonal antibodies and proteins.
• Reported to CFO
• Led negotiations on more than six technology deals; including a pre-clinical collaboration with Millennium Pharmaceuticals in 2002 that had a $37 Million upfront payment.
• Conducted Market Research and Competitive Intelligence activities that assessed market need, financial potential, and barriers to entry (physician/patient attitudes, product usability, reimbursement).
• Provided actionable recommendations to product teams and senior management including: commercial assessments, forecasts and life-cycle plans.
• Commercial launch lead for Raptiva®, an anti-CD11a humanized monoclonal antibody approved for Psoriasis, with partner GenentechProduct Pipeline Therapeutic markets included: Oncology (CLL, Colorectal Cancer, Prostate.

Burlington, Massachusetts, US

Decision Resources, Inc. provides syndicated market research, advisory services, and consulting for the pharmaceutical, biotechnology, and healthcare technology companies (200-500 employees). Led research teams and projects from cradle to grave. Conceived ideas for research and report topics, built research plans, wrote survey instruments, weighted and.

Boston, MA, US

• Wrote policy responses to proposed legislation and lobbied for and/or against certain health policy measures at the State and Federal level.
• Ran analytical reports using the State’s all-payer claims database to drill into patient claims and aggregate procedure-level cost data in order to quantify costs and inform policy decisions for healthcare bills and.
• Program Manager to 2 of the largest Health Insurance Providers, the State's PPO plan (Tufts Health plan) and the State's PBM (Pharmacy Benefits Manager (Merck Medco).
• In 1998 I was assigned the responsibilities of interim Budget Director, leading the daily management and reporting of the Group Health Insurance Commission’s (GIC) $600M budget to the Executive Director, GIC Board, and.

Master Of Business Administration - Mba, Finance, General

Master Of Business Administration - Mba

Global Economics & Marketing Classes With Joseph E. Stiglitz And Bruce Greenwald

Bachelor Of Science - Bs, Cell/Cellular And Molecular Biology